Condition: Acute Monocytic Leukemia · Newly Diagnosed · Sponsor: The First Affiliated Hospital of Soochow University
This study is to investigate the therapeutic efficacy and side effect of venetoclax, azacytidine combined with chidamide for newly diagnosed acute monocytic leukemia patients that are ineligible for intensive chemotherapy
This description comes directly from the study's public registry record.
Sheng-Li Xue, M. D. · 008651267781139 · slxue@suda.edu.cn
Always discuss trial participation with your own doctor first.
| The First Affliated Hospital of Soochow University | Suzhou, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05566054